Fair Value Calculator Fair Value Calculator
EN DE

SAMPRE (SAMPRE) Fair Value & Analysis

IN · Market cap ₹655M

S SAMPRE SAMPRE · BSE
Price₹7.50
Fair Value₹5.55
Upside-26.0%
Quality33/100
Watch SAMPRE for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹3.88 – ₹7.21

Fair value as of: Jul 6, 2026

From 15 valuation models · updated today

Share price −40.6% over the past month.

Price vs Fair Value (12 months)

₹41.50 ₹7.45 Fair Value ₹5.55 Jul 2025 Jul 2026

12‑month range ₹7.45 – ₹41.50 · fair‑value band ₹3.88 – ₹7.21 · the ₹7.50 price screens above the ₹5.55 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

SAMPRE (SAMPRE) currently trades at ₹7.50, while our model-based Fair Value estimate is ₹5.55 — implying the stock looks roughly 26.0% overvalued today. We read business quality at 33/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, SAMPRE generated revenue of ₹433M at a net margin of 7.1%. Revenue grew 94.4% year over year. It earns a return on equity of 3.1%. Net debt stands at ₹178M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹3.88 (bear case) to ₹7.21 (bull case); at ₹7.50, the current price sits above that range.

Key figures & financial health

Revenue (TTM) ₹433M
Revenue growth (YoY) +94.4%
Net margin 7.1%
Return on equity 3.1%
Free cash flow −₹33.8M FY2025
P/E ratio 5.1
More key figures
Operating margin -0.8%
EPS (TTM) ₹1.46
EPS growth (YoY) +215%
Net debt ₹178M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

SAMPRE reported revenue of ₹433M in FY2025 versus ₹231M in FY2021, a compound +17.0%/yr. Reported net income was ₹30.8M in FY2025, compounding +77.8%/yr from FY2021.

Revenue +17.0%/yr
FY21 ₹231M
FY22 ₹371M
FY23 ₹251M
FY24 ₹251M
FY25 ₹433M
Net income +77.8%/yr
FY21 ₹3.1M
FY22 ₹3.5M
FY23 ₹2.3M
FY24 −₹76.7M
FY25 ₹30.8M

Is SAMPRE fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "SAMPRE Fair Value". https://www.fairvalue-calculator.com/stock/SAMPRE

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is SAMPRE (SAMPRE) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹5.55 versus a price of ₹7.50 — about −26% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SAMPRE?
Our model-based fair value for SAMPRE is ₹5.55 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹7.50.
What is the quality score of SAMPRE?
SAMPRE has a Quality Score of 33/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of SAMPRE (SAMPRE)?
SAMPRE reported trailing-twelve-month revenue of about ₹433M (latest available figure, as of Jul 6, 2026).
What is the net profit margin of SAMPRE?
The net profit margin of SAMPRE is about 7.1%, meaning it keeps roughly 7.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.